JPMorgan Cuts Xylem to Underweight From Neutral
JPMorgan cut its price target for Xylem to $90 per share from $118 per share.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
JPMorgan cuts Xylem to underweight, lowers target to $90
JPMorgan cut its rating on Xylem from neutral to underweight and lowered its price target from $118 to $90.